Literature DB >> 18773860

Association of interleukin-18 gene promoter polymorphism on the risk of cervix carcinogenesis in north Indian population.

Ranbir Chander Sobti1, Mohammad Shekari, Dor Mohammad Kordi Tamandani, Keyanoosh Malekzadeh, Vanita Suri.   

Abstract

Cervical cancer is one of the most common neoplastic diseases affecting women, with a combined worldwide incidence of almost half a million new cases. Considering the fact that IL-18 plays an important role in the interactions among T cells, NK cells, and macrophages and induces IFN-gamma production, efforts should be made to understand the clinical impact of IL-18 cytokine in patients with solid malignancies, as not much study has been conducted in cervix carcinoma. In this study, we have observed in GC genotype statistically significant marginal increased risk of developing of cervical cancer (OR 1.8, 95% CI 1.17-2.76, p = 0.006). Similarly, when the GC with CC genotypes were combined results were once more statistically significant with borderline risk of developing cervix cancer (OR 1.6,95% CI 1.09-2.50, p = 0.01). Likewise, we found statistically significant increased risk between cases and controls in GC genotype and passive smokers with risk of cervical cancer (OR 4.3, 95%CI 2.13-8.99, p = 0.00001). Our investigation suggests that IL-18 gene -137 in different genotypes, as also in passive smokers, may increase risk of cervix carcinogenesis in north Indian women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773860     DOI: 10.3727/096504008785114156

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  8 in total

1.  The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies.

Authors:  Tie-Jun Liang; Hui Ma; Cong-Xiao Wang; Yin-Rong Liu; Xing-Guo Wang
Journal:  Tumour Biol       Date:  2013-06-22

Review 2.  Review and pooled analysis of studies on -607(C/A) and -137(G/C) polymorphisms in IL-18 and cancer risk.

Authors:  Yuan-Yuan Mi; Qian-Qian Yu; Meng-Lei Yu; Bin Xu; Li-Feng Zhang; Wei Cheng; Wei Zhang; Li-Xin Hua; Ning-Han Feng
Journal:  Med Oncol       Date:  2010-05-20       Impact factor: 3.064

3.  Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies.

Authors:  Xin Yang; Man-Tang Qiu; Jing-Wen Hu; Feng Jiang; Ming Li; Jie Wang; Qin Zhang; Rong Yin; Lin Xu
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

4.  IL-18, but not IL-12, induces production of IFN-γ in the immunosuppressive environment of HPV16 E7 transgenic hyperplastic skin.

Authors:  Stephen R Mattarollo; Antje Blumenthal; Christina Gosmann; Ian H Frazer
Journal:  J Invest Dermatol       Date:  2014-04-22       Impact factor: 8.551

5.  The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.

Authors:  Serap Yalçın; Pelin Mutlu; Türker Çetin; Meral Sarper; Gökhan Özgür; Ferit Avcu
Journal:  Turk J Haematol       Date:  2014-05-21       Impact factor: 1.831

6.  Identification of differential plasma miRNA profiles in Chinese workers with occupational lead exposure.

Authors:  Ming Xu; Zhengmin Yu; Feifei Hu; Hongbing Zhang; Lixin Zhong; Lei Han; Yan An; Baoli Zhu; Hengdong Zhang
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

7.  Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.

Authors:  Wojciech Krajewski; Lidia Karabon; Anna Partyka; Anna Tomkiewicz; Sławomir Poletajew; Andrzej Tukiendorf; Anna Kołodziej; Romuald Zdrojowy
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

8.  Effects of interleukin-18 promoter (C607A and G137C) gene polymorphisms and their association with oral squamous cell carcinoma (OSCC) in northern India.

Authors:  Prithvi Kumar Singh; Mohd Kaleem Ahmad; Vijay Kumar; Syed Rizwan Hussain; Rajni Gupta; Amita Jain; Abbas Ali Mahdi; Jaishri Bogra; Girish Chandra
Journal:  Tumour Biol       Date:  2014-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.